Palisade Bio (PALI) Restructuring Costs (2013 - 2026)

Palisade Bio (PALI) has 4 years of Restructuring Costs data on file, last reported at $4.2 million in Q1 2026.

• Quarterly Restructuring Costs rose 213.14% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 million (up 91.8% YoY) and the FY2025 annual result came in at $7.6 million, up 38.37% from the prior year.
• Restructuring Costs advanced to $4.2 million in Q1 2026 per PALI's latest filing, from $3.6 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $4.2 million in Q1 2026 and bottomed at $1.1 million in Q2 2025.
• The 3-year median for Restructuring Costs is $1.4 million (2024), against an average of $1.9 million.
• The widest annual swing landed in 2025, when Restructuring Costs dropped 22.6%; it then soared 213.14% in 2026.
• Tracing PALI's Restructuring Costs over 3 years: stood at $1.4 million in 2024, then soared by 158.13% to $3.6 million in 2025, then gained by 18.15% to $4.2 million in 2026.
• Per Business Quant, the three latest PALI Restructuring Costs figures stand at $4.2 million (Q1 2026), $3.6 million (Q4 2025), and $1.5 million (Q3 2025).

Peer Comparison